{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:17:27Z","timestamp":1758637047806,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>There are substantial barriers to conducting research among individuals with stigmatized and complicated health conditions like substance use disorders. These barriers slow progress when developing, refining, and assessing interventions to better treat underserved populations. Virtual focus groups are an innovative method for collecting data from individuals via a discreet and accessible platform which can inform novel as well as existing treatment approaches. This article reports on the feasibility and acceptability of virtual focus groups as a mechanism to recruit and engage geographically and demographically diverse samples of participants with substance use disorders that are otherwise logistically difficult to assess.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Participants were assessed for eligibility for a virtual focus group study based on demographic features, drug use history, and psychiatric history via a remote, interview-based screening. Focus groups were completed anonymously without video or name-sharing. Discussion contributions, quantified with number of times speaking and total number of words spoken, were compared across gender, and treatment status. Participants provided quantitative and qualitative feedback on the focus group experience in a follow-up survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Focus groups (<jats:italic>N<\/jats:italic>=26) based in geographical areas throughout the United States were conducted with 88 individuals with opioid use disorder or stimulant use disorder. Discussion contributions were comparable between genders and among individuals in treatment versus those seeking treatment. A follow-up survey (<jats:italic>n<\/jats:italic>=50, 57% of focus group participants) reflected high levels of enjoyment, comfort, and honesty during focus group discussions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Findings suggest virtual focus groups can be an effective and efficient tool for substance use research.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1352300","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:04:11Z","timestamp":1710133451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population"],"prefix":"10.3389","volume":"15","author":[{"given":"Cecilia L.","family":"Bergeria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem Umang","family":"Satyavolu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220699","article-title":"Opioid use disorder: pernicious and persistent","volume":"179","author":"Bergeria","year":"2022","journal-title":"Am J Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/s0033291714000129","article-title":"What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies","volume":"45","author":"Clement","year":"2015","journal-title":"Psychol Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12913-019-4721-x","article-title":"Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000510","article-title":"Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review","volume":"29","author":"Nalven","year":"2021","journal-title":"Exp Clin Psychopharmacol"},{"key":"B5","article-title":"The representation of females in clinical trials for substance use disorder conducted in the United States, (2010\u201319)","volume-title":"Addiction","author":"Gunn","year":"2022"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100084","article-title":"Under-representation of key demographic groups in opioid use disorder trials","volume":"4","author":"Rudolph","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6980","article-title":"Virtual versus in-person focus groups: comparison of costs, recruitment, and participant logistics","volume":"19","author":"Rupert","year":"2017","journal-title":"J Med Internet Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J013v31n04_01","article-title":"Women\u2019s work roles and their impact on health, well-being, and career: comparisons between the United States, Sweden, and The Netherlands","volume":"31","author":"Gjerdingen","year":"2001","journal-title":"Women Health"},{"key":"B9","unstructured":"ZamarroG\n            Perez-ArceF\n            PradosMJ\n          KTLAGender differences in the impact of COVID-192020"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/yco.0000000000000794","article-title":"Virtual recruitment and participant engagement for substance use research during a pandemic","volume":"35","author":"Hoeflich","year":"2022","journal-title":"Curr Opin Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.jsat.2021.108544","article-title":"The impact of COVID-19 on substance use disorder treatment in California: Service providers\u2019 perspectives","volume":"133","author":"Lin","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2023.1113891","article-title":"Identifying barriers and facilitators for implementing harm reduction strategies for methamphetamine use into hospital settings","volume":"3","author":"Forchuk","year":"2023","journal-title":"Front Health Serv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108425","article-title":"Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health","volume":"126","author":"Hammond","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12737","article-title":"Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: A cross-sectional survey","volume":"39","author":"Button","year":"2022","journal-title":"J Rural Health"},{"volume-title":"Patient-Focused Drug Development Guidance Public Workshop: Methods to Identify What is Important to Patients and Select, Develop or Modify Fit-for-Purpose Clinical Outcome Assessments, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research","year":"2018","key":"B15"},{"key":"B16","unstructured":"Public Meeting on Patient-focused Drug Development for Opioid Use Disorder (OUD)2018"},{"volume-title":"Patient-Focused Drug Development Guidance Public Workshop: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making, Center for Drug Evaluation and Research","year":"2019","key":"B17"},{"volume-title":"Diagnostic and statistical manual of mental disorders","year":"2013","key":"B18"},{"key":"B19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12874-018-0594-7","article-title":"Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period","volume":"18","author":"Vasileiou","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J Nervous Ment Dis"},{"key":"B21","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","author":"Sheehan","year":"1998","journal-title":"J\u00a0Clin Psychiatry"},{"key":"B22","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"B23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1037\/0022-3514.85.4.756","article-title":"Les passions de l\u2019ame: on obsessive and harmonious passion","volume":"85","author":"Vallerand","year":"2003","journal-title":"J Pers Soc Psychol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphys.2015.07.001","article-title":"The brief pain inventory (BPI)","volume":"62","author":"Poquet","year":"2016","journal-title":"J Physiother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106701","article-title":"Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial","volume":"114","author":"Kendzor","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2022.05.006","article-title":"Practical technology for expanding and improving substance use disorder treatment: telehealth, remote monitoring, and digital health interventions","volume":"45","author":"Sweeney","year":"2022","journal-title":"Psychiatr Clin North Am"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/BF00987314","article-title":"Focus groups: A new tool for qualitative research","volume":"7","author":"Morgan","year":"1984","journal-title":"Qual Sociol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1586\/erp.11.12","article-title":"Interpreting patient-reported outcome results: US FDA guidance and emerging methods","volume":"11","author":"McLeod","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1352300\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:04:16Z","timestamp":1710133456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1352300\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":29,"alternative-id":["10.3389\/fpsyt.2024.1352300"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1352300","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"article-number":"1352300"}}